Access to advances in cardiology

Lancet

Volumn 350, Issue 9085, 1997, Pages 1162-1163

  Lye, Michael ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYPOCHOLESTEROLEMIC AGENT;

ACUTE HEART INFARCTION; AGED; BLOOD CLOT LYSIS; CARDIOVASCULAR DISEASE; GERIATRIC CARE; HEALTH CARE AVAILABILITY; HEART FAILURE; HUMAN; LIFESTYLE; MEDICAL RESEARCH; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0030693733     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)08414-6     Document Type: Article

References (20)

1. Gottlieb S, Goldbourt U, Boyko V, et al. Improved outcome of elderly patients (≥75 years of age) with acute myocardial infarction from 1981-1983 to 1992-1994 in Israel. Circulation 1997; 95: 342-50.
2. European Secondary Prevention Study Group. Translation of clinical trials into practice: a European population-based study of the use of thrombolysis for acute myocardial infarction. Lancet 1996; 347: 1203-07.
3. Ramanathan K. Ellis CJ, White HD. Thrombolytic therapy in the elderly: pharmacoeconomic considerations. Drugs Aging 1996; 8: 237-44.
4. Abrahamsson P, Dellborg M, Swedberg K. Active treatment of acute myocardial-infarction on mortality and recovery in very elderly patients. Cardiol Elderly 1996; 4: 89-92.
5. Hall AS, Murray GD, Ball SG. Follow-up study of patients randomly allocated ramipril or placebo for heart failure after acute myocardial infarction: AIRE Extension (AIREX) study. Lancet 1997; 349: 1493-97.
6. Krumholz HM, Vaccarino V, Ellerbeck EF, et al. Determinants of appropriate use of angiotensin-converting enzyme inhibitors after acute myocardial infarction in persons ≥65 years of age. Am J Cardiol 1997; 79: 581-86.
7. Adams JN, Jamieson M, Rawles JM, Trent RJ, Jennings KP. Women and myocardial infarction: agism rather than sexism. Br Heart J 1995; 73: 87-91.
8. Jollis JG, Delong ER, Peterson ED, et al. Outcome of acute myocardial infarction according to the specialty of the admitting physician. N Engl J Med 1996; 335: 1880-87.
9. Evans JG. The rationing debate - rationing health care by age: the case against. BMJ 1997; 314: 822-25.
10. Cohn JN. Drug therapy: the management of chronic heart failure. N Engl J Med 1996; 335: 490-98.
11. The Task Force of the Working Group on Heart Failure of the European Society of Cardiology. The treatment of heart failure. Eur Heart J 1997; 18: 736-53.
12. Fishkind D, Paris BEG, Aronow WS. Use of digoxin, diuretics, beta blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers in older patients in an academic hospital-based geriatrics practice. J Am Geriat Soc 1997; 45: 809-12.
13. Lye M. Chronic cardiac failure in the elderly. In: Brocklehurst JC, Tallis RC, Fillit HM, eds. Textbook of geriatric medicine and gerontology, 5th ed. Edinburgh: Churchill Livingstone (in press).
14. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336: 525-33.
15. Newman J, Ahmed O, Hyngstrom T, et al. Heart failure treatment with angiotensin-converting enzyme inhibitors in hospitalized Medicare patients in 10 large states. Arch Intern Med 1997; 157: 1103-08.
16. O'Keeffe ST, Lye M. Heart failure in the elderly: the same syndrome as the clinical trials? In: McMurray JJV, Cleland JGF, eds. Heart failure in clinical practice. 1st ed. London: Martin Dunitz, 1996: 47-71.
17. Pitt B, Segal R, Martinez FA, et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 1997; 349: 747-52.
18. Playford DA, Watts GF. Management of lipid disorders in the elderly. Drugs Aging 1997; 10: 444-62.
19. Ramsay LE, Haq IU, Jackson PR, Yeo WW, Pickin DM, Payne JN. targeting lipid lowering drug therapy for primary prevention of coronary disease - an updated Sheffield table. Lancet 1996; 348: 387-88.
20. NHS Executive. SMAC statement on use of statins (EL[97]41). Wetherby, Yorkshire: Department of Health, 1997.